The field of human germline genome editing (HGGE) offers a promising reproductive potential to prevent inheritance of genetic diseases, yet also opens the door to undesirable eugenics. This stirred the debate about the acceptability of HGGE in light of human rights, particularly human dignity. The European Convention of Human Rights (ECHR) and the European Court of Human Rights (ECtHR) use human dignity as a guiding principle. Therefore, this article examined the clinical implementation of HGGE in light of relevant case-law regarding Article 2 and Article 8 ECHR. The analysis illustrates that the ECtHR broadens the scope of artificial reproductive rights under Article 8, however, Contracting States of the Council of Europe can limit these rights and the accessibility to reproductive techniques, such as HGGE. The ECtHR remains elusive about the legal status of unborn life, but protection under Article 2 with the introduction of HGGE should not be ruled out.

中文翻译：

---

欧洲人权法院与人类种系基因组编辑的出现

人类种系基因组编辑领域（HGGE）为防止遗传疾病的遗传提供了有希望的生殖潜力，但也为不良的优生学打开了大门。这引发了关于其可接受性的争论HGGE考虑到人权，特别是人的尊严。欧洲人权公约（欧洲人权法院）和欧洲人权法院（ECtHR）将人的尊严作为指导原则。因此，本文探讨了临床实施HGGE根据有关第 2 条和第 8 条的相关判例法欧洲人权法院。分析表明，欧洲人权法院扩大了第 8 条规定的人工生殖权利的范围，但是，欧洲委员会的缔约国可以限制这些权利以及生殖技术的可及性，例如HGGE。欧洲人权法院对于未出生生命的法律地位仍然难以捉摸，但根据第 2 条的规定提供了保护HGGE不应该排除。